Clinical Trials Directory

Trials / Completed

CompletedNCT04140747

Transfer of Strictly Anaerobe Microbes From Mother to Child

Transfer of Strictly Anaerobe Microbes From Mother to Child - a Pilot Study

Status
Completed
Phase
Study type
Observational
Enrollment
94 (actual)
Sponsor
Medical University of Graz · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study aims to investigate the changes in the microbiota at different body sites in late pregnancy, in comparison with non-pregnant women, with particular emphasis on archaea, and to identify possible maternal-to-child transfer routes for acquisition of strictly anaerobic microorganisms by analyzing the gut microbiota of new born infants (delivered vaginally or by C-section).

Detailed description

The investigators hypothesize that changes occur in the microbial community during pregnancy in different body sites (vagina, oral etc.) and that the main source of these microorganisms is the mother for vaginally born infants, while C-section born infants acquire most of the anaerobic microbial communities from other sources rather than mother's vaginal and gut microbiota, such as the environment. Specific Research Objectives will be: 1. To investigate diversity of archaea in the vagina of healthy women in the context with community state types (CSTs), and compare vaginal microbiome in pregnant with non-pregnant healthy women. 2. To identify the presence of archaea in different body sites (oral, gut) or body fluids (amniotic fluid, urine, human milk) within the perinatal microbial communities. 3. To investigate the presence of archaea in the infant's first-days-of-life intestinal community, and to identify the sources of these microorganisms by using source tracking approach. 4. To investigate Human Milk Oligosaccharides (HMOs) in maternal (serum, saliva, urine, breast milk) or intrauterine sources (amniotic fluid) as potential modifiers of the microbial communities in these sites. 5. To analyze associations of maternal/ intrauterine HMOs with infant HMOs and microbiota (meconium and infant stool) in order to investigate vertical transmission of microbiota to the infant.

Conditions

Timeline

Start date
2016-10-07
Primary completion
2022-01-01
Completion
2022-01-01
First posted
2019-10-28
Last updated
2024-08-27

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT04140747. Inclusion in this directory is not an endorsement.